Mexico COFEPRIS registration 1495R2019 SSA

ANTI-THYROID ANTIBODIES CONTROL WIENER LAB

EN: ANTI-THYROID ANTIBODIES CONTROL WIENER LAB
Mexico flagMexico·Clase I·III. DIAGNOSTIC AGENTS·REPRESENTACIONES LABIN MÉXICO, S.A. DE C.V.·Registered July 30, 2019
Product Use / Uso del Producto
Spanish

PARA EL CONTROL DE CALIDAD EN LA DETERMINACIÓN CUANTITATIVA DE ANTICUERPOS ANTI-TIROIDEOS, UTILIZANDO ANALIZADORES WIENER LAB. CLIA SERIES. AGENTE DE DIAGNÓSTICO PARA USO IN VITRO. PARA USO EXCLUSIVO EN LABORATORIOS CLÍNICOS O DE GABINETE.

English

FOR QUALITY CONTROL IN THE QUANTITATIVE DETERMINATION OF ANTI-THYROID ANTIBODIES, USING WIENER LAB ANALYZERS. CLIA SERIES. DIAGNOSTIC AGENT FOR IN VITRO USE. FOR USE IN CLINICAL OR CABINET LABORATORIES ONLY.

Device classification
Risk Class / Clase de Riesgo
Clase I
Product Type (Spanish)
III. AGENTES DE DIAGNÓSTICO
Product Type (English)
III. DIAGNOSTIC AGENTS
Trade Name (Spanish)
REACTIVO CONTROL
Trade Name (English)
REACTIVE CONTROL
Registration information
Analysis ID
1495R2019 SSA
Registration Date
July 30, 2019
Manufacturer / Fabricante
Name (English)
REPRESENTACIONES LABIN MÉXICO, S.A. DE C.V.
About this record

Access comprehensive regulatory information for ANTI-THYROID ANTIBODIES CONTROL WIENER LAB (ANTI-THYROID ANTIBODIES CONTROL WIENER LAB) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 1495R2019 SSA and manufactured by REPRESENTACIONES LABIN MÉXICO, S.A. DE C.V.. The device was registered on July 30, 2019.

This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.

Free DatabasePowered by Pure Global AICOFEPRIS Official DataClase I